| Serial Number | 79343517 |
| Word Mark | JENDII |
| Filing Date | Friday, January 21, 2022 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, July 26, 2023 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Anti-bacterial pharmaceutical preparations; barks for pharmaceutical purposes; biological preparations for pharmaceutical purposes; capsules for pharmaceutical purposes; capsules for veterinary pharmaceutical preparations; chemical preparations containing enzymes for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; chemical products for pharmaceutical use; chemicals for pharmaceutical use; decoctions for pharmaceutical purposes; decongestive pharmaceutical preparations being inhalants; digestives for pharmaceutical purposes; effervescent pharmaceutical preparations; effervescent analgesic pharmaceutical preparations; extracts of plants in capsule form (for pharmaceutical use); hormone preparations for pharmaceutical use; lotions for pharmaceutical purposes; medical foodstuff additives for pharmaceutical use; modified starches for pharmaceutical purposes; moist paper hand towels impregnated with a pharmaceutical lotion; moist wipes impregnated with a pharmaceutical lotion; moistened paper tissues impregnated with a pharmaceutical lotion; natural pharmaceutical products; natural starches for pharmaceutical purposes; oils for pharmaceutical purposes; pain killers (pharmaceuticals); pharmaceutical appetite suppressants; pharmaceutical creams; pharmaceutical preparations being antiulceratives; pharmaceutical preparations being antacids; pharmaceutical preparations; pharmaceutical preparations being hormone preparations for human use; pharmaceutical preparations containing essential oils; pharmaceutical preparations containing vitamins; pharmaceutical preparations containing royal jelly; pharmaceutical preparations for alleviating disorders of the brain; pharmaceutical preparations for animals; pharmaceutical preparations for application to the skin; pharmaceutical preparations for assisting the prevention of bone diseases; pharmaceutical preparations for enteral administration; pharmaceutical preparations for health care; pharmaceutical preparations for human use; pharmaceutical preparations for oral use; pharmaceutical preparations for personal use; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention of bone conditions; pharmaceutical preparations for the relief of insect bites; pharmaceutical preparations for the relief of insect stings; pharmaceutical preparations for the therapeutic treatment of diabetes mellitus; pharmaceutical preparations for the topical treatment of dermatological disorders; pharmaceutical preparations for the treatment of blackheads; pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for the treatment of depressive illness; pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of digestive maladies; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of disorders of the gastro-enterological tract; pharmaceutical preparations for the treatment of gastric diseases; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of gynaecological disorders; pharmaceutical preparations for the treatment of joint related diseases; pharmaceutical preparations for the treatment of pimples; pharmaceutical preparations for the treatment of premenstrual tension; pharmaceutical preparations for the treatment of psoriasis; pharmaceutical preparations for the treatment of psoriasis in human beings; pharmaceutical preparations for the treatment of spots; pharmaceutical preparations for the treatment of the eyes; pharmaceutical preparations for topical use; pharmaceutical preparations for use as laxative; pharmaceutical preparations for use in gynaecology; pharmaceutical preparations for use in the treatment of arthritis; pharmaceutical preparations for use in the treatment of arthrosis; pharmaceutical preparations for use in the treatment of colostomy patients; pharmaceutical preparations for use in the treatment of hormonal disorders; pharmaceutical preparations for use in the treatment of ileostomy patients; pharmaceutical preparations for use in the treatment of muscle tension; pharmaceutical preparations for use in the treatment of pimples; pharmaceutical preparations for use in the treatment of rheumatism; pharmaceutical preparations for use in the treatment of sciatica; pharmaceutical preparations for use in the treatment of skin blemishes; pharmaceutical preparations for use in the treatment seborrheic dermatitis; pharmaceutical preparations for use in with an automated bacterial protection; pharmaceutical preparations for veterinary use; pharmaceutical preparations in the form of tablets; pharmaceutical products; pharmaceutical products derived from natural sources; pharmaceutical products for combating metabolism disorders; pharmaceutical products for metabolic disorders; pharmaceutical products for the central nervous system; pharmaceutical products for the stimulation of growth; pharmaceutical products for the treatment of blood circulation diseases; pharmaceutical products for the treatment of dysfunctions of metabolism; pharmaceutical products for the treatment of gastrointestinal disorders; pharmaceutical products for the treatment of osteoporosis; pharmaceutical products for use by humans; pharmaceutical products in gel form; pharmaceutical products in the nature of anthelmintic preparations; pharmaceutical solutions for topical irrigation purposes; pharmaceutical substances; pharmaceutical sweets; pharmaceutical tablets; pharmaceutical tonic preparations; plant extracts for pharmaceutical purposes; plant extracts for pharmaceutical use; preparations for application to the body (pharmaceuticals); preparations for application to the skin (pharmaceuticals); preparations for body care (pharmaceuticals); preparations of plants for pharmaceutical use; tablets (pharmaceuticals); topical pharmaceutical compositions; transdermal patches containing pharmaceutical preparations for application to the skin; transdermal patches for administering pharmaceuticals; wipes (tissues) impregnated with pharmaceutical lotions |
| Translation of Words in Mark | The wording "JENDII" has no meaning in a foreign language. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 6, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | BIOACTIVE LABORATORIES PTY LTD |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 82 - NOT AVAILABLE |
| Address | AU |
| Event Date | Event Description |
| Tuesday, November 1, 2022 | ASSIGNED TO EXAMINER |
| Thursday, June 30, 2022 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, July 5, 2022 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Wednesday, July 6, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, July 12, 2022 | APPLICATION FILING RECEIPT MAILED |
| Saturday, September 17, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Wednesday, November 2, 2022 | NON-FINAL ACTION WRITTEN |
| Thursday, November 3, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, January 12, 2023 | REFUSAL PROCESSED BY MPU |
| Thursday, January 12, 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Wednesday, February 1, 2023 | REFUSAL PROCESSED BY IB |
| Wednesday, July 26, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, July 26, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Wednesday, July 26, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| Monday, July 29, 2024 | FINAL DISPOSITION NOTICE SENT TO IB |
| Saturday, August 17, 2024 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Saturday, July 27, 2024 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Wednesday, December 6, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, December 6, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Monday, December 25, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |